Breast Cancer,TNBC (Triple Negative Breast Cancer) Neoadjuvant Atezo + CT Followed by Open-Label Adjuvant Atezo in pts with eTNBC Jul 28, 2023
Breast Cancer,Other Cancers Capivasertib and Fulvestrant for Pts With AI-Resistant HR+/HER2 ABC Jul 28, 2023
Breast Cancer Examining Radiotherapy Utilization and LRR Incidence in Favorable-Risk, Node-Positive Breast Cancer Patients Jul 26, 2023
Breast Cancer Efficacy of Metronomic Oral Vinorelbine vs. IV Paclitaxel in ER+ MBC Patients Jul 20, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Durvalumab Combinations in TNBC: Promising Results with D+Paclitaxel (Phase 1b/2 Study) Jun 30, 2023
Breast Cancer ALTTO Phase III : Impact of Diabetes, Insulin, and Metformin on HER2+ Breast Cancer Outcome Jun 30, 2023
